Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage

Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia

1997 • 1,647 citations

Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

1998 • 780 citations

The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP

2000 • 770 citations

PREPARATION AND PROPERTIES

1966 • 332 citations

Preparation and Properties of Zn-α2-glycoprotein of Normal Human Plasma

1961 • 264 citations

Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.

1998 • 248 citations

Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress

2002 • 242 citations

UCP2 and UCP3 rise in starved rat skeletal muscle but mitochondrial proton conductance is unchanged

1999 • 235 citations

Purification and characterization of a tumor lipid-mobilizing factor.

1998 • 180 citations

Review of the Toxicology of Paraquat (1, 1′-Dimethyl-4, 4′-bipyridinium Chloride)

1979 • 169 citations

Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes

1999 • 156 citations

Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: Correlation with stage and performance status

2001 • 155 citations

Tumor necrosis factor increases mitochondrial oxidant production and induces expression of uncoupling protein-2 in the regenerating rat liver

1999 • 155 citations

Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor

2002 • 124 citations

Thiazolidinediones Stimulate Uncoupling Protein-2 Expression in Cell Lines Representing White and Brown Adipose Tissues and Skeletal Muscle

1998 • 107 citations

Management of cancer cachexia.

1985 • 91 citations

Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARα-mediated pathway

2001 • 78 citations

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor

2002 • 75 citations

Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes.

1996 • 74 citations

Therapeutic Index: A Vital Component in Selection of Anticancer Agents for Clinical Trial

1989 • 63 citations

On the mechanism of reductive activation in the mode of action of some anticancer drugs

1982 • 51 citations

Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARγ and aP2 genes in adipose tissue: possible features of the antiobesity effects of a β3-adrenergic agonist 1 1Abbreviations: AP2, adipocyte specific fatty acid binding protein; BAT, brown adipose tissue; DIO, diet-induced obesity; HFD, high-fat diet; PPARγ, peroxisome proliferator-activated receptor gamma; RXRα, retinoid X receptor alpha; RARα, retinoid acid receptor alpha; UCP, uncoupling protein; WAT, white …

2001 • 50 citations

Up‐regulation of uncoupling proteins by β‐adrenergic stimulation in L6 myotubes

2001 • 49 citations

Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes.

1987 • 36 citations

The interaction of bifunctional alkylating agents with the DNA of tumour cells

1976 • 27 citations

Some Biologic Characteristics of Transplantable Lines of Mouse Adenocarcinomas of the Colon<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>

1980 • 20 citations